Novo Nordisk A/S Share Price Today: Live Updates & Key Insights

Novo Nordisk A/S share price today is $36.73, up -1.48%. The stock opened at $36.48 against the previous close of $37.08, with an intraday high of $36.995 and low of $36.175.

Novo Nordisk A/S Share Price Chart

Novo Nordisk A/S

us-stock
To Invest in {{usstockname}}
us-stock

Novo Nordisk A/S Share Price Performance

$36.73 -0.0148(-1.48%) NVO at 23 Mar 2026 02:32 PM Drug Manufacturers - General
Lowest Today 36.175
Highest Today 36.995
Today’s Open 36.48
Prev. Close 37.08
52 Week High 80.53
52 Week Low 35.85
Day’s Range: Low 36.175 High 36.995
52-Week Range: Low 35.85 High 80.53
1 day return -
1 Week return -5.4
1 month return -7.89
3 month return -24.14
6 month return -39.88
1 year return -51.54
3 year return -50.29
5 year return +2.84
10 year return -

Novo Nordisk A/S Institutional Holdings

Loomis, Sayles & Company LP 0.39

Franklin Resources Inc 0.31

Bank of America Corp 0.30

Morgan Stanley - Brokerage Accounts 0.28

Capital Research & Mgmt Co - Division 3 0.25

JPMorgan Chase & Co 0.24

Folketrygdfondet 0.23

FMR Inc 0.23

Fisher Asset Management, LLC 0.22

Putnam Large Cap Value A 0.17

Putnam US Large Cap Value Equity 0.17

Citadel Advisors Llc 0.17

The Goldman Sachs Group Inc 0.15

Everett Harris & Co 0.14

State Farm Mutual Automobile Ins Co 0.14

State Street Corp 0.14

Boston Partners Global Investors, Inc 0.12

T. Rowe Price Associates, Inc. 0.11

VOLORIDGE INVESTMENT MANAGEMENT, LLC 0.11

Loomis Sayles Growth Y 0.11

Royal Bank of Canada 0.11

Northern Trust Corp 0.10

Fayez Sarofim & Company 0.10

T. Rowe Price International Gr Eq Tr-D 0.08

NT EAFE Index Fund - NL 0.08

American Funds Washington Mutual A 0.07

Capital Group Wash Mutual Invtrs Comp 0.07

T. Rowe Price International Stock 0.07

T. Rowe Price Health Sciences 0.07

T. Rowe Price International Growth Eq 0.07

American Funds American Balanced A 0.05

Loomis Sayles Large Cap Growth Trust B 0.05

Amana Growth Investor 0.05

NT EAFE Index Fund - L 0.04

JHancock Disciplined Value I 0.04

Loomis Sayles US Growth Eq I/A USD 0.04

Putnam Large Cap Value Trust IA 0.04

Putnam Focused Large Cap Value ETF 0.04

VanEck Pharmaceutical ETF 0.03

Carmignac Patrimoine A EUR Acc 0.03

Novo Nordisk A/S Market Status

Strong Buy: 4

Buy: 1

Hold: 5

Sell: 1

Strong Sell: 1

Novo Nordisk A/S Fundamentals

Market Cap 162839.18 M

PB Ratio 5.4507

PE Ratio 10.3484

Enterprise Value 178001.41 M

Total Assets 542902.00 M

Volume 26367715

Novo Nordisk A/S Company Financials

Annual Revenue FY25:297195194000 297195.2M, FY24:290403000000 290403.0M, FY23:null 0.0M, FY22:176954000000 176954.0M, FY21:140800000000 140800.0M

Annual Profit FY25:238769487000 238769.5M, FY24:245881000000 245881.0M, FY23:null 0.0M, FY22:148506000000 148506.0M, FY21:117142000000 117142.0M

Annual Net worth FY25:98500286000 98500.3M, FY24:100988000000 100988.0M, FY23:null 0.0M, FY22:55525000000 55525.0M, FY21:47757000000 47757.0M

Quarterly Revenue Q4/2025:78434812000 78434.8M, Q3/2025:74976000000 74976.0M, Q2/2025:76857000000 76857.0M, Q1/2025:78087000000 78087.0M, Q4/2024:85683000000 85683.0M

Quarterly Profit Q4/2025:63422549000 63422.5M, Q3/2025:57072000000 57072.0M, Q2/2025:64011000000 64011.0M, Q1/2025:65197000000 65197.0M, Q4/2024:72659000000 72659.0M

Quarterly Net worth Q4/2025:26650037000 26650.0M, Q3/2025:20006000000 20006.0M, Q2/2025:26503000000 26503.0M, Q1/2025:29034000000 29034.0M, Q4/2024:28230000000 28230.0M

About Novo Nordisk A/S & investment objective

Company Information Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Organisation Drug Manufacturers - General

Employees 68794

Industry Drug Manufacturers - General

CEO Ms. Elin Jager

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Novo Nordisk A/S FAQs

What is the share price of Novo Nordisk A/S today?

The current share price of Novo Nordisk A/S is $36.73.

Can I buy Novo Nordisk A/S shares in India?

Yes, Indian investors can buy Novo Nordisk A/S shares by opening an international trading and demat account with Motilal Oswal.

How to buy Novo Nordisk A/S shares in India?

You can easily invest in Novo Nordisk A/S shares from India by:

Can I buy fractional shares of Novo Nordisk A/S?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Novo Nordisk A/S?

Novo Nordisk A/S has a market cap of $162839.18 M.

In which sector does Novo Nordisk A/S belong?

Novo Nordisk A/S operates in the Drug Manufacturers - General sector.

What documents are required to invest in Novo Nordisk A/S stocks?

To invest, you typically need:

What is the PE and PB ratio of Novo Nordisk A/S?

The PE ratio of Novo Nordisk A/S is 10.35 and the PB ratio is 5.45.